Clinical Trial Update: Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors

View source ↗

Summary

A clinical trial update shows the study evaluating ClearView for association with cardiac risk factors has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Snippet

Sponsor: Epic Research & Diagnostics, Inc. | Conditions: Cardiovascular Diseases, Coronary Artery Disease | Status: SUSPENDED